“The UW Program for Advanced Cell Therapy (PACT) will use the personalized cell therapy treatment to study its effects on a viral infection faced by around 30-40% of kidney and/or pancreas transplant recipients.
Nearly one in three children is infected with CMV by age 5, according to the Centers for Disease Control and Prevention. It can cause fever, sore throat, fatigue, and swollen glands. For people with stable immune systems, the virus is usually kept in check and doesn't cause symptoms. For transplant patients, their immune system is suppressed and an infection could be fatal.